A carregar...
Evolution of the Thrombolytic Treatment Window for Acute Ischemic Stroke
Ischemic stroke is a major cause of morbidity and mortality for which the only approved treatment in the acute setting is intravenous thrombolysis. The efficacy and safety of recombinant tissue plasminogen activator (rt-PA) have been firmly established within 3 h of symptom onset; however, few patie...
Na minha lista:
| Main Authors: | , |
|---|---|
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Current Science Inc.
2010
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2828551/ https://ncbi.nlm.nih.gov/pubmed/20425223 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s11910-009-0076-8 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|